Estrella Historical Financial Ratios

ESLAW Stock

0.09 0.00 0.00%

Estrella Immunopharma is recently reporting on over 61 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as PTB Ratio of 8.39 or Days Sales Outstanding of 0.0 will help investors to properly organize and evaluate Estrella Immunopharma financial condition quickly.

Quick Ratio Current Ratio

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Estrella Immunopharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

For more information on how to buy Estrella Stock please use our How to Invest in Estrella Immunopharma guide.

About Estrella Financial Ratios Analysis

Estrella ImmunopharmaFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Estrella Immunopharma investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Estrella financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Estrella Immunopharma history.

Estrella Immunopharma Financial Ratios Chart

Average Payables Cash Per Share Income Quality Current Ratio

Add Fundamental

Average Payables

The average amount owed to suppliers and creditors over a specific period, reflecting the company's payment cycle and credit terms with suppliers.

Income Quality

An assessment of the sustainability of a company's earnings over time, considering factors like revenue source diversification and cost structure.

Current Ratio

A liquidity ratio that measures a company's ability to pay short-term obligations or those due within one year. It compares a firm's current assets to its current liabilities.

Most ratios from Estrella Immunopharma's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Estrella Immunopharma current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Estrella Immunopharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

For more information on how to buy Estrella Stock please use our How to Invest in Estrella Immunopharma guide.

Estrella Immunopharma fundamentals Correlations

	Ptb Ratio	Book Value Per Share	Free Cash Flow Yield	Operating Cash Flow Per Share	Average Payables	Pb Ratio	Free Cash Flow Per Share	Roic	Net Income Per Share	Cash Per Share	Pocfratio	Capex To Operating Cash Flow	Pfcf Ratio	Income Quality	Roe	Ev To Operating Cash Flow	Pe Ratio	Return On Tangible Assets	Ev To Free Cash Flow	Earnings Yield	Net Debt To E B I T D A	Current Ratio	Tangible Book Value Per Share	Graham Number	Shareholders Equity Per Share	Debt To Equity
Ptb Ratio		0.87	-0.58	-0.76	-1.0	1.0	-0.76	-0.94	-0.65	-1.0	0.83	0.79	0.83	0.66	-0.94	0.83	0.82	-0.32	0.83	-0.61	-1.0	0.23	0.87	0.64	0.87	-0.74
Book Value Per Share	0.87		-0.1	-0.43	-0.87	0.87	-0.43	-0.65	-0.52	-0.91	0.7	0.53	0.7	0.2	-0.65	0.69	0.69	0.19	0.69	-0.14	-0.89	-0.28	1.0	0.94	1.0	-0.64
Free Cash Flow Yield	-0.58	-0.1		0.84	0.57	-0.58	0.84	0.82	0.48	0.5	-0.55	-0.7	-0.55	-0.99	0.82	-0.55	-0.55	0.96	-0.55	1.0	0.54	-0.93	-0.1	0.26	-0.1	0.42
Operating Cash Flow Per Share	-0.76	-0.43	0.84		0.76	-0.76	1.0	0.87	0.87	0.71	-0.91	-0.74	-0.91	-0.83	0.87	-0.91	-0.91	0.68	-0.91	0.89	0.74	-0.63	-0.43	-0.13	-0.43	0.56
Average Payables	-1.0	-0.87	0.57	0.76		-1.0	0.76	0.94	0.65	1.0	-0.83	-0.78	-0.83	-0.65	0.94	-0.83	-0.82	0.31	-0.83	0.6	1.0	-0.23	-0.87	-0.65	-0.87	0.74
Pb Ratio	1.0	0.87	-0.58	-0.76	-1.0		-0.76	-0.94	-0.65	-1.0	0.83	0.79	0.83	0.66	-0.94	0.83	0.82	-0.32	0.83	-0.61	-1.0	0.23	0.87	0.64	0.87	-0.74
Free Cash Flow Per Share	-0.76	-0.43	0.84	1.0	0.76	-0.76		0.87	0.87	0.71	-0.91	-0.74	-0.91	-0.83	0.87	-0.91	-0.91	0.68	-0.91	0.89	0.74	-0.63	-0.43	-0.13	-0.43	0.56
Roic	-0.94	-0.65	0.82	0.87	0.94	-0.94	0.87		0.64	0.9	-0.8	-0.84	-0.8	-0.87	1.0	-0.8	-0.79	0.63	-0.8	0.84	0.93	-0.55	-0.65	-0.34	-0.65	0.69
Net Income Per Share	-0.65	-0.52	0.48	0.87	0.65	-0.65	0.87	0.64		0.64	-0.96	-0.53	-0.96	-0.45	0.64	-0.96	-0.97	0.29	-0.96	0.57	0.64	-0.23	-0.52	-0.35	-0.52	0.48
Cash Per Share	-1.0	-0.91	0.5	0.71	1.0	-1.0	0.71	0.9	0.64		-0.82	-0.75	-0.82	-0.58	0.91	-0.82	-0.81	0.23	-0.82	0.53	1.0	-0.14	-0.91	-0.71	-0.91	0.74
Pocfratio	0.83	0.7	-0.55	-0.91	-0.83	0.83	-0.91	-0.8	-0.96	-0.82		0.67	1.0	0.56	-0.8	1.0	1.0	-0.31	1.0	-0.62	-0.83	0.24	0.7	0.49	0.7	-0.61
Capex To Operating Cash Flow	0.79	0.53	-0.7	-0.74	-0.78	0.79	-0.74	-0.84	-0.53	-0.75	0.67		0.67	0.75	-0.84	0.67	0.66	-0.54	0.67	-0.72	-0.77	0.48	0.53	0.27	0.53	-0.94
Pfcf Ratio	0.83	0.7	-0.55	-0.91	-0.83	0.83	-0.91	-0.8	-0.96	-0.82	1.0	0.67		0.56	-0.8	1.0	1.0	-0.31	1.0	-0.62	-0.83	0.24	0.7	0.49	0.7	-0.61
Income Quality	0.66	0.2	-0.99	-0.83	-0.65	0.66	-0.83	-0.87	-0.45	-0.58	0.56	0.75	0.56		-0.87	0.56	0.56	-0.92	0.56	-0.98	-0.63	0.89	0.2	-0.16	0.2	-0.48
Roe	-0.94	-0.65	0.82	0.87	0.94	-0.94	0.87	1.0	0.64	0.91	-0.8	-0.84	-0.8	-0.87		-0.8	-0.79	0.62	-0.8	0.83	0.93	-0.55	-0.65	-0.34	-0.65	0.69
Ev To Operating Cash Flow	0.83	0.69	-0.55	-0.91	-0.83	0.83	-0.91	-0.8	-0.96	-0.82	1.0	0.67	1.0	0.56	-0.8		1.0	-0.31	1.0	-0.62	-0.82	0.24	0.69	0.49	0.69	-0.61
Pe Ratio	0.82	0.69	-0.55	-0.91	-0.82	0.82	-0.91	-0.79	-0.97	-0.81	1.0	0.66	1.0	0.56	-0.79	1.0		-0.32	1.0	-0.62	-0.82	0.25	0.69	0.48	0.69	-0.61
Return On Tangible Assets	-0.32	0.19	0.96	0.68	0.31	-0.32	0.68	0.63	0.29	0.23	-0.31	-0.54	-0.31	-0.92	0.62	-0.31	-0.32		-0.31	0.94	0.28	-1.0	0.19	0.52	0.19	0.23
Ev To Free Cash Flow	0.83	0.69	-0.55	-0.91	-0.83	0.83	-0.91	-0.8	-0.96	-0.82	1.0	0.67	1.0	0.56	-0.8	1.0	1.0	-0.31		-0.62	-0.82	0.24	0.69	0.49	0.69	-0.61
Earnings Yield	-0.61	-0.14	1.0	0.89	0.6	-0.61	0.89	0.84	0.57	0.53	-0.62	-0.72	-0.62	-0.98	0.83	-0.62	-0.62	0.94	-0.62		0.58	-0.9	-0.14	0.21	-0.14	0.44
Net Debt To E B I T D A	-1.0	-0.89	0.54	0.74	1.0	-1.0	0.74	0.93	0.64	1.0	-0.83	-0.77	-0.83	-0.63	0.93	-0.82	-0.82	0.28	-0.82	0.58		-0.2	-0.89	-0.67	-0.89	0.74
Current Ratio	0.23	-0.28	-0.93	-0.63	-0.23	0.23	-0.63	-0.55	-0.23	-0.14	0.24	0.48	0.24	0.89	-0.55	0.24	0.25	-1.0	0.24	-0.9	-0.2		-0.28	-0.6	-0.28	-0.17
Tangible Book Value Per Share	0.87	1.0	-0.1	-0.43	-0.87	0.87	-0.43	-0.65	-0.52	-0.91	0.7	0.53	0.7	0.2	-0.65	0.69	0.69	0.19	0.69	-0.14	-0.89	-0.28		0.94	1.0	-0.64
Graham Number	0.64	0.94	0.26	-0.13	-0.65	0.64	-0.13	-0.34	-0.35	-0.71	0.49	0.27	0.49	-0.16	-0.34	0.49	0.48	0.52	0.49	0.21	-0.67	-0.6	0.94		0.94	-0.48
Shareholders Equity Per Share	0.87	1.0	-0.1	-0.43	-0.87	0.87	-0.43	-0.65	-0.52	-0.91	0.7	0.53	0.7	0.2	-0.65	0.69	0.69	0.19	0.69	-0.14	-0.89	-0.28	1.0	0.94		-0.64
Debt To Equity	-0.74	-0.64	0.42	0.56	0.74	-0.74	0.56	0.69	0.48	0.74	-0.61	-0.94	-0.61	-0.48	0.69	-0.61	-0.61	0.23	-0.61	0.44	0.74	-0.17	-0.64	-0.48	-0.64

Click cells to compare fundamentals

Estrella Immunopharma Account Relationship Matchups

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
GM	General Motors
F	Ford Motor

Additional Tools for Estrella Stock Analysis

When running Estrella Immunopharma's price analysis, check to measure Estrella Immunopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Estrella Immunopharma is operating at the current time. Most of Estrella Immunopharma's value examination focuses on studying past and present price action to predict the probability of Estrella Immunopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Estrella Immunopharma's price. Additionally, you may evaluate how the addition of Estrella Immunopharma to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Price To Sales Ratio	Dividend Yield
Ptb Ratio	Days Sales Outstanding
Book Value Per Share	Free Cash Flow Yield
Invested Capital	Operating Cash Flow Per Share
Average Payables	Stock Based Compensation To Revenue
Capex To Depreciation	Pb Ratio
Ev To Sales	Free Cash Flow Per Share
Roic	Inventory Turnover
Net Income Per Share	Days Of Inventory On Hand
Payables Turnover	Sales General And Administrative To Revenue
Average Inventory	Research And Ddevelopement To Revenue
Capex To Revenue	Cash Per Share
Pocfratio	Interest Coverage
Payout Ratio	Capex To Operating Cash Flow
Pfcf Ratio	Days Payables Outstanding
Net Current Asset Value	Income Quality
Roe	Tangible Asset Value
Ev To Operating Cash Flow	Pe Ratio
Return On Tangible Assets	Ev To Free Cash Flow
Earnings Yield	Intangibles To Total Assets
Net Debt To E B I T D A	Current Ratio
Tangible Book Value Per Share	Receivables Turnover
Graham Number	Shareholders Equity Per Share
Debt To Equity	Capex Per Share
Graham Net Net	Average Receivables
Revenue Per Share	Interest Debt Per Share
Debt To Assets	Enterprise Value Over E B I T D A
Short Term Coverage Ratios	Price Earnings Ratio
Price Book Value Ratio	Price Earnings To Growth Ratio
Days Of Payables Outstanding	Dividend Payout Ratio
Price To Operating Cash Flows Ratio	Price To Free Cash Flows Ratio
Pretax Profit Margin	Ebt Per Ebit
Operating Profit Margin	Effective Tax Rate
Company Equity Multiplier	Long Term Debt To Capitalization
Total Debt To Capitalization	Return On Capital Employed
Debt Equity Ratio	Ebit Per Revenue
Quick Ratio	Dividend Paid And Capex Coverage Ratio
Net Income Per E B T	Cash Ratio
Operating Cash Flow Sales Ratio	Days Of Inventory Outstanding
Days Of Sales Outstanding	Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios	Price To Book Ratio
Fixed Asset Turnover	Capital Expenditure Coverage Ratio
Price Cash Flow Ratio	Enterprise Value Multiple
Debt Ratio	Cash Flow To Debt Ratio
Price Sales Ratio	Return On Assets
Asset Turnover	Net Profit Margin
Gross Profit Margin	Price Fair Value
Return On Equity

Estrella Historical Financial Ratios

About Estrella Financial Ratios Analysis

Estrella Immunopharma Financial Ratios Chart

Average Payables

Income Quality

Current Ratio

Estrella Immunopharma fundamentals Correlations

Estrella Immunopharma Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Also Currently Popular

Additional Tools for Estrella Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Pb Ratio	+ 1.0	Ptb Ratio
Tangible Book Value Per Share	+ 1.0	Book Value Per Share
Shareholders Equity Per Share	+ 1.0	Book Value Per Share
Earnings Yield	+ 1.0	Free Cash Flow Yield
Free Cash Flow Per Share	+ 1.0	Operating Cash Flow Per Share
Cash Per Share	+ 1.0	Average Payables

Current Ratio	- 1.0	Return On Tangible Assets
Net Debt To E B I T D A	- 1.0	Pb Ratio
Cash Per Share	- 1.0	Pb Ratio
Pb Ratio	- 1.0	Average Payables
Net Debt To E B I T D A	- 1.0	Ptb Ratio
Cash Per Share	- 1.0	Ptb Ratio